21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients

BACKGROUND: Comprehensive investigations of the associations between 21-gene recurrence assay and metabolic profiles in Chinese breast cancer patients are limited. METHODS: We evaluated the relations of the 21-gene recurrence risk score (RS) and the expression of cancer-related genes with metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yifei, Wang, Tiange, Tong, Yiwei, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385488/
https://www.ncbi.nlm.nih.gov/pubmed/34456877
http://dx.doi.org/10.3389/fendo.2021.725161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385488/
https://www.ncbi.nlm.nih.gov/pubmed/34456877
http://dx.doi.org/10.3389/fendo.2021.725161

Ejemplares similares